Director of Hepatology Research, Cleveland Clinic, United States
🌟 Dr. Omar Sims is an esteemed Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, United States. With a profound dedication to hepatology research, he also serves as the Director of Hepatology Research at the Cleveland Clinic Foundation. Dr. Sims specializes in Hepatitis C (HCV), HIV/HCV co-infection, epidemiology of HCV, nonalcoholic fatty liver disease (NAFLD), and the impacts of alcohol and substance use on liver health. His work addresses health disparities and promotes a deeper understanding of liver diseases. 📚 His extensive career combines academic excellence and impactful research aimed at improving global health outcomes. 🌍
Publication Profile
Google Scholar
Education
🎓 Dr. Sims earned his PhD in 2011 from the prestigious University of Georgia in Athens, Georgia, USA. His advanced education laid the foundation for a successful career in hepatology and public health. 📖
Experience
💼 Over his career, Dr. Sims has held numerous esteemed positions: Associate Professor of Medicine (2023-present) at Cleveland Clinic Lerner College of Medicine. Director of Hepatology Research (2023-present) at Cleveland Clinic Foundation. Associate Professor (2015-2023) at the University of Alabama at Birmingham. Assistant Professor (2013-2015) at the University of Alabama. Full-time Lecturer (2011-2012) at Kennesaw State University
Research Interests
🔬 Dr. Sims is passionate about exploring Hepatitis C (HCV), HIV/HCV co-infections, NAFLD, and substance-related liver diseases. His research delves into health disparities, liver disease progression, and strategies to improve transplant outcomes, making a significant impact in public health and hepatology. 🌐
Awards
🏆 Dr. Sims has received recognition for his groundbreaking work in hepatology and epidemiology. While specific awards are not listed, his role in leading research projects at prominent institutions reflects his excellence and dedication.
Publications
Effects of Tobacco Smoking on Post-Liver-Transplant Outcomes – Transplantology, 2024
Post Liver Transplant Short-Term and Survival Outcomes in Patients Living with Obesity – Digestive and Liver Disease, 2024
Combined Heart-Liver Transplant vs. Heart Transplant Alone: A Single Center Experience – Transplantology, 2024
The Long-Term Effect of Weight Loss on the Prevention of Progression to Cirrhosis among Patients with Obesity and MASH-Related F3 Liver Fibrosis – International Journal of Environmental Research and Public Health, 2024
A Comparison Between Patients with Various Etiologies of Cirrhosis and Examination of Cardiac Risk Factors Limiting Survival to Liver Transplantation – Clinical Transplantation, 2024